about
Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease.Neuropsychiatric characteristics of GBA-associated Parkinson disease.Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease Cognition.Relationship of age of onset and family history in Parkinson disease.Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.Handedness and motor symptom asymmetry in Parkinson's disease.Mitochondria-derived oxidative stress induces a heat shock protein response.Gemifloxacin-associated neurotoxicity presenting as encephalopathy.LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseFunctional electrical stimulation for the treatment of lower extremity dystonia.Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Genetics and pharmacological treatment of dystonia.Glucocerebrosidase enzyme activity in GBA mutation Parkinson's diseaseAutosomal recessive inheritance of ADCY5-related generalized dystonia and myoclonus.Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.22q11.2 deletion syndrome presenting with early-onset Parkinson's disease.MM1-Type Sporadic Creutzfeldt-Jakob Disease With Early Behavioral Changes and Prolonged Symptom Duration.Dementia with Lewy bodies advances: A new consensus report.Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.Capgras Syndrome in Advanced Parkinson's Disease.Disparities in deep brain stimulation surgery among insured elders with Parkinson disease.Selection of normative group affects rates of mild cognitive impairment in Parkinson's disease.Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN.Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson diseaseFocused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of lifeLower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson diseasePredictors of health-related quality of life in Parkinson's diseaseClinical and demographic correlates of apathy in Parkinson's diseaseComparison of Parkinson's Disease Patients' Characteristics by Indication for Deep Brain Stimulation: Men Are More Likely to Have DBS for TremorTherapeutic approaches to cholinergic deficiency in Lewy body diseases
P50
Q30252794-B4E3DE52-DE62-43FA-9CFB-C71B10219DCAQ30275630-877EF89E-23ED-4A1A-98E0-AA1C4369419EQ30277323-B5196245-DEDF-4173-BB91-F0DBC998E746Q30300452-97E2A68C-97AD-4212-A66D-F8C3AAA2FD60Q30409165-DA328BAE-FF4A-4F3F-9535-43EF00380BCCQ30418038-879351C0-F305-4E54-8963-266069A4CBCFQ30434542-2FF188F3-4CD1-461C-A991-66B906999B03Q30447997-C3B759AC-6DA0-452D-B6C1-7D7462D7564BQ34299954-9B73625F-EAC2-4D8F-A48C-20D33BBE4CB8Q36988965-24510E83-1ED8-41C8-8CF3-34898D6021E2Q37385032-32664BB4-1115-413C-B614-247D6A0F379DQ37930044-5EE46FE4-9188-435C-93FD-E4C14FEA489CQ40994106-62B20C58-18CE-46CD-8CD6-A0C7371693EEQ42164510-630DADEF-6BE2-4308-9F5A-337C578D25EDQ44824443-B62F5D88-58D3-4828-AA66-CA492F709CA2Q45016592-15228055-5423-4CAC-BF75-0E8DC277E757Q45031971-0F80B085-06A4-491E-ADEF-688057F9369DQ45060916-BE90E504-DD95-4BC7-9E8C-FA497BA13141Q45063971-446FD3FC-9407-4309-B467-FA7C30A8FB50Q45072830-F674215F-F45D-4F19-943E-53B9D46961CEQ48473570-0CA0D66B-6DB6-47C8-895D-E095649FD1DDQ50015936-773DBD02-11C6-4E88-84E7-AE7F5444A9BFQ55110763-482EE95A-EE1A-48D4-823B-A89A420C012AQ55497857-577CA34A-8CA6-4E3B-B06C-888434C3A4BFQ56378847-8099CD5A-AF48-402C-A991-57C520A31432Q57049065-F5A70951-5DF2-4BB7-BE62-EF6A40308964Q64764529-E619069D-1F60-4F7D-A0E8-30651CE1DBD5Q64764805-616087AE-C18B-4D9D-9526-68FBDE3BFE5EQ64786346-FCB297AE-E682-4503-8F99-68DEBC07603EQ90402914-F5F51BEB-D199-463E-8160-52CC5C2D27EEQ90436205-D1DC242A-DE02-4AA4-85A4-C2A0E7569557
P50
description
neurology researcher
@en
onderzoeker
@nl
հետազոտող
@hy
name
Matthew J Barrett
@ast
Matthew J Barrett
@en
Matthew J Barrett
@es
Matthew J Barrett
@nl
type
label
Matthew J Barrett
@ast
Matthew J Barrett
@en
Matthew J Barrett
@es
Matthew J Barrett
@nl
altLabel
Matthew Barrett
@en
prefLabel
Matthew J Barrett
@ast
Matthew J Barrett
@en
Matthew J Barrett
@es
Matthew J Barrett
@nl
P106
P31
P4012
P496
0000-0003-4480-0221